J. M. Ávila

Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction

J. Smolen, D. Aletaha, J. M. Ávila, 2011, Annals of the rheumatic diseases.

Clinical and epidemiological research

F. Guillemin, A. Saraux, E. Spitz, 2011 .